Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation (Q44057933)

29 November 2017

Synthesis and characterization of a catalytic antibody-HPMA copolymer-Conjugate as a tool for tumor selective prodrug activation (English)

1 reference

29 November 2017

1

1 reference

29 November 2017

Holger N Lode

3

0 references

author name string

Wolfgang Wrasidlo

series ordinal

2

1 reference

PubMed ID

12110325

29 November 2017

Doron Shabat

series ordinal

4

1 reference

PubMed ID

12110325

29 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Bioorganic & Medicinal Chemistry

29 November 2017

1 reference

29 November 2017

10

1 reference

29 November 2017

9

1 reference

29 November 2017

3023-3029

1 reference

Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

The pharmacokinetics of polymer-bound adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Determination of a new polymer-bound paclitaxel derivative (PNU 166945), free paclitaxel and 7-epipaclitaxel in dog plasma and urine by reversed-phase high-performance liquid chromatography with UV detection

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Phase I and pharmacologic study of oral (PEG-1000) 9-aminocamptothecin in adult patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Drug monitoring of low-dose PEG-asparaginase (Oncaspar) in children with relapsed acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Developments with targeted enzymes in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Antibody directed enzyme prodrug therapy (ADEPT). A review of some theoretical, experimental and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Anti-tumor effects of antibody-alkaline phosphatase conjugates in combination with etoposide phosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Efficient aldolase catalytic antibodies that use the enamine mechanism of natural enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Multiple event activation of a generic prodrug trigger by antibody catalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Enantioselective aldol cyclodehydrations catalyzed by antibody 38C2.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Alchemy, enzymes, and the blind-watchmaker

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Toward antibody-directed "abzyme" prodrug therapy, ADAPT: carbamate prodrug activation by a catalytic antibody and its in vitro application to human tumor cell killing

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Prodrug activation via catalytic antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Synthesis and characterization of monoclonal antibody-beta-lactamase conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Reconstructing Aldolase Antibodies to Alter Their Substrate Specificity and Turnover

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Evaluation of protein-N-(2-hydroxypropyl)methacrylamide copolymer conjugates as targetable drug carriers. 1. Binding, pinocytic uptake and intracellular distribution of transferrin and anti-transferrin receptor antibody conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Synthetic Polymers Conjugated to Monoclonal Antibodies: Vehicles for Tumour-Targeted Drug Delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Antiproliferative effect of a lectin- and anti-Thy-1.2 antibody-targeted HPMA copolymer-bound doxorubicin on primary and metastatic human colorectal carcinoma and on human colorectal carcinoma transfected with the mouse Thy-1.2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

Polymeric drugs based on conjugates of synthetic and natural macromolecules. II. Anti-cancer activity of antibody or (Fab')(2)-targeted conjugates and combined therapy with immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900156-6

7 January 2021

10.1016/S0968-0896(02)00156-6

Identifiers

DOI

1 reference

29 November 2017

1 reference

PubMed ID

12110325